Latest Cancer News

Novel Agent Granted Fast Track Designation for Refractory Metastatic Colorectal Cancer (10-23-2014)
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAS-102, a novel agent currently under investigation for the treatment of refractory metastatic colorectal cancer. According... Continue Reading

FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC (10-22-2014)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (10-21-2014)
The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

More Cancer News

Locations

Oncology Offices:
DAVENPORT
40107 HW 27 N.
Davenport, FL 33837
TEL: (863) 419-0692
FAX: (863) 419-1695
Open Monday through Friday 8:00 AM – 4:30 PM
LAKE WALES
2 State Rd. 60 West
Lake Wales FL 33853
TEL: (863) 679-2960
FAX: (863) 679-2781
Open Monday through Friday 8:00 AM – 4:30 PM
 
 
Urology Offices:
DAVENPORT
40107 HW 27 N.
Davenport, FL 33837
TEL: (863) 419-0692
FAX: (863) 419-1695
LAKE WALES
22 State Rd. 60 West
Lake Wales FL 33853
TEL: 863-679-3800
FAX: 863-679-9086
 
WINTER HAVEN
201 Magnolia Ave. S.W.
Winter Haven, FL 33880
PH: 863-293-6375
Fax: 863-293-8877
Open Monday through Friday 8:00 am to 4:30 pm.